LV12259B - NEW R-ALFA-PROPILPIPERONYLAMINE AND ITS ANALOGUE SYNTHESIS - Google Patents

NEW R-ALFA-PROPILPIPERONYLAMINE AND ITS ANALOGUE SYNTHESIS Download PDF

Info

Publication number
LV12259B
LV12259B LVP-98-185A LV980185A LV12259B LV 12259 B LV12259 B LV 12259B LV 980185 A LV980185 A LV 980185A LV 12259 B LV12259 B LV 12259B
Authority
LV
Latvia
Prior art keywords
compound
acid
alcohol
formula
hydrogen
Prior art date
Application number
LVP-98-185A
Other languages
English (en)
Latvian (lv)
Other versions
LV12259A (lv
Inventor
Hui-Yin Li
Luigi Anzalone
Robert Eugene Waltermire
Original Assignee
Dupont Pharmaceuticals Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dupont Pharmaceuticals Company filed Critical Dupont Pharmaceuticals Company
Publication of LV12259A publication Critical patent/LV12259A/xx
Publication of LV12259B publication Critical patent/LV12259B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58Radicals substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
LVP-98-185A 1996-03-22 1998-09-21 NEW R-ALFA-PROPILPIPERONYLAMINE AND ITS ANALOGUE SYNTHESIS LV12259B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1395596P 1996-03-22 1996-03-22
PCT/US1997/003466 WO1997034887A1 (en) 1996-03-22 1997-03-17 NOVEL ASYMMETRIC SYNTHESIS OF R-α-PROPYL-PIPERONYL AMINE AND ITS ANALOGS

Publications (2)

Publication Number Publication Date
LV12259A LV12259A (lv) 1999-04-20
LV12259B true LV12259B (en) 1999-09-20

Family

ID=21762727

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-98-185A LV12259B (en) 1996-03-22 1998-09-21 NEW R-ALFA-PROPILPIPERONYLAMINE AND ITS ANALOGUE SYNTHESIS

Country Status (23)

Country Link
US (1) US5932749A (cs)
EP (1) EP0888329A1 (cs)
JP (1) JP2000506891A (cs)
KR (1) KR20000064735A (cs)
CN (1) CN1218463A (cs)
AR (1) AR006521A1 (cs)
AU (1) AU719633B2 (cs)
BR (1) BR9708233A (cs)
CA (1) CA2249401A1 (cs)
CZ (1) CZ295098A3 (cs)
EA (1) EA001207B1 (cs)
EE (1) EE9800299A (cs)
HR (1) HRP970165A2 (cs)
IL (1) IL126223A0 (cs)
LT (1) LT4540B (cs)
LV (1) LV12259B (cs)
NO (1) NO984344D0 (cs)
NZ (1) NZ331875A (cs)
PL (1) PL329070A1 (cs)
SI (1) SI9720023A (cs)
SK (1) SK127398A3 (cs)
WO (1) WO1997034887A1 (cs)
ZA (1) ZA972342B (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5587299A (en) 1998-08-31 2000-03-21 Du Pont Pharmaceuticals Company An efficient process for the preparation of a human leukocyte elastase inhibitor
US6825351B2 (en) * 2001-09-12 2004-11-30 Anormed, Inc. Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
WO2010077798A2 (en) * 2008-12-15 2010-07-08 Taigen Biotechnology Co., Ltd. Stereoselective synthesis of piperidine derivatives
AR090100A1 (es) 2012-02-21 2014-10-22 Celgene Corp Procesos para la preparacion de la (s)-1-(3-etoxi-4-metoxifenil)-2-metanosulfoniletilamina
US9126906B2 (en) 2012-02-21 2015-09-08 Celgene Corporation Asymmetric synthetic processes for the preparation of aminosulfone compounds
US11357742B2 (en) 2015-12-14 2022-06-14 X4 Pharmaceuticals, Inc. Methods for treating cancer
WO2017106328A1 (en) 2015-12-14 2017-06-22 X4 Pharmaceuticals, Inc. Methods for treating cancer
CA3009176A1 (en) 2015-12-22 2017-06-29 X4 Pharmaceuticals, Inc. Methods for treating immunodeficiency disease
CN109153722A (zh) 2016-04-08 2019-01-04 X4 制药有限公司 用于治疗癌症的方法
CN116554168B (zh) 2016-06-21 2025-09-23 X4制药有限公司 Cxcr4抑制剂及其用途
JP7084624B2 (ja) 2016-06-21 2022-06-15 エックス4 ファーマシューティカルズ, インコーポレイテッド Cxcr4阻害剤およびその使用
US11332470B2 (en) 2016-06-21 2022-05-17 X4 Pharmaceuticals, Inc. CXCR4 inhibitors and uses thereof
US10548889B1 (en) 2018-08-31 2020-02-04 X4 Pharmaceuticals, Inc. Compositions of CXCR4 inhibitors and methods of preparation and use
EP4117662A4 (en) 2020-03-10 2024-04-03 X4 Pharmaceuticals, Inc. METHODS OF TREATING NEUTROPENIA
MX2024002291A (es) 2021-09-01 2024-06-28 Empathbio Inc Sintesis de mdma o sus isomeros de mdma opticamente activos (r)- o (s).
EP4401725A1 (en) * 2021-09-17 2024-07-24 atai Life Sciences AG Preparation of optically active enantiomers of piperonyl amines by resolution of the diastereomeric salts
EP4408832A1 (en) 2021-10-01 2024-08-07 Empathibio, Inc. Novel prodrugs of mdma, mda, and derivatives thereof
EP4457222A2 (en) 2021-12-28 2024-11-06 EmpathBio, Inc. Nitric oxide releasing prodrugs of mda and mdma

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3819438A1 (de) * 1987-06-30 1989-01-19 Basf Ag Verfahren zur herstellung von optisch aktiven 1-arylethylaminen
IL99658A0 (en) * 1990-10-15 1992-08-18 Merck & Co Inc Substituted azetidinones and pharmaceutical compositions containing them
US5149838A (en) * 1991-09-20 1992-09-22 Merck & Co., Inc. Intermediates for substituted azetidinones useful as anti-inflammatory and antidegenerative agents

Also Published As

Publication number Publication date
NO984344L (no) 1998-09-18
SI9720023A (sl) 1999-04-30
AR006521A1 (es) 1999-09-08
CN1218463A (zh) 1999-06-02
BR9708233A (pt) 2000-01-04
EP0888329A1 (en) 1999-01-07
IL126223A0 (en) 1999-05-09
EA199800844A1 (ru) 1999-02-25
EE9800299A (et) 1999-06-15
ZA972342B (en) 1998-09-18
US5932749A (en) 1999-08-03
JP2000506891A (ja) 2000-06-06
CZ295098A3 (cs) 1999-03-17
NO984344D0 (no) 1998-09-18
LT4540B (lt) 1999-08-25
AU719633B2 (en) 2000-05-11
CA2249401A1 (en) 1997-09-25
WO1997034887A1 (en) 1997-09-25
EA001207B1 (ru) 2000-12-25
KR20000064735A (ko) 2000-11-06
HRP970165A2 (en) 1998-04-30
LV12259A (lv) 1999-04-20
LT98132A (en) 1999-03-25
PL329070A1 (en) 1999-03-15
SK127398A3 (en) 1999-04-13
NZ331875A (en) 2000-01-28
AU2196897A (en) 1997-10-10

Similar Documents

Publication Publication Date Title
LV12259B (en) NEW R-ALFA-PROPILPIPERONYLAMINE AND ITS ANALOGUE SYNTHESIS
JP5254836B2 (ja) ベナゼプリル及びその類似体の生産に有用な中間体の速度論的分離
KR100794091B1 (ko) 2-에톡시-3-(4-히드록시페닐)프로판산 및 그의 유도체의 (s)-거울상이성질체의 제조 방법
CA2431400C (en) Process for preparing isomers of salbutamol
KR100712003B1 (ko) 펜세린 및 그 유사체의 제조방법
JP2007525532A (ja) N−アルキル−n−メチル−3−ヒドロキシ−3−(2−チエニル)−プロピルアミンの製造方法
JPH0469145B2 (cs)
WO2016115962A1 (zh) 一种奈必洛尔中间体的制备方法及奈必洛尔的制备方法
CA2276074A1 (en) Efficient synthesis of a chiral mediator
CN1989097A (zh) 用于制备非对映异构体富集的化合物的方法
JPH10218847A (ja) タートラニル酸の製造法
MXPA98007673A (en) New asymmetric synthesis of r-alpha-propil-piperonil amine and its analo
CN114621126B (zh) 一种改进的依折麦布的制备方法
JP2002371060A (ja) 光学活性アミノピペリジン誘導体の製造方法
JP3010756B2 (ja) 光学活性アルコールの製造方法
JP4338979B2 (ja) ビペリデン(i)の製造方法
CN111333544A (zh) 一种用于合成尼拉帕尼的中间体及其制备方法
JP2013129642A (ja) 光学活性3,4−ビス(アルキルオキシカルボニル)−1,6−ヘキサン二酸誘導体の製造法
CN119874543A (zh) N,n-二甲基-2-[2-(2-丙烯-1-基氧基)乙氧基]-乙胺的合成方法
CN115784907A (zh) 一种dl-去氧肾上腺素的制备方法
HK1060345B (en) Process for preparing isomers of salbutamol
JPH08183779A (ja) 光学活性ピペラジン誘導体の製造方法および製造の中間体
JPWO2002044136A1 (ja) N保護−β−アミノアルコールの製造法およびN保護−β−アミノエポキシドの製造法
JPH041744B2 (cs)
HK1020281A (en) NOVEL ASYMMETRIC SYNTHESIS OF R-α-PROPYL-PIPERONYL AMINE AND ITS ANALOGUES